Private Equity Liquidity Events
Carlyle Group sells nearly 11% stake in pharma co. Viyash Scientific for Rs.1,259.4 Cr
Hyderabad-based, listed pharmaceutical company Viyash Scientific (formerly known as Sequent Scientific), saw its PE investor, Carlyle Group (via CA Hull Investments and CA Harbor Investments) sell a 10.88% stake via open market transactions on August 26. The sale fetched a total of INR 1,259.4-Cr.Founded in 1985, Viyash manufactures active pharmaceutical ingredients (APIs), advanced intermediates, and finished medicine formulations for human and animal health.
Company website ↗ (opens in a new tab)
Between Jul 2015 and May 2020, SeQuent Scientific had attracted about $ 169 M from Ascent Capital, Convergent Finance, Carlyle.For FY26, SeQuent Scientific had reported about INR 1,382 Cr in Operating Income and about INR 76 Cr in PAT.